Patient selection for a curative approach to carcinomatosis

Pompiliu Piso, Gabriel Glockzin, Phillip Von Breitenbuch, Talal Sulaiman, Felix Popp, Marc Dahlke, Jesus Esquivel, Hans Juergen Schlitt

Research output: Contribution to journalArticle

Abstract

There is an increasing evidence showing that in selected patients with peritoneal carcinomatosis cytoreductive surgery and hyperthermic intraperitoneal chemotherapy may improve survival. Adequate patient selection is crucial to obtain a complete macroscopic cytoreduction, a leading predictor of patient outcome. However, selection is a very difficult process and is associated with a significant learning curve. Many selection criteria have to be assessed in each patient: performance status, comorbiditites, response to previous chemotherapies, histology grading, and presence of extra-abdominal or liver metastases, small bowel involvement, and tumor volume assessed by the peritoneal cancer index. All these factors have to be discussed interdisciplinary and with the patient to create an individualized treatment strategy. It is difficult to decide the relative importance of each selection criteria. However, completeness of cytoreduction, tumor volume, and histology grading are most important in many multivariate analysis independent prognostic factors. For appropriate selected patients with peritoneal carcinomatosis arising from appendiceal and colon cancer, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy should be considered standard of care.

Original languageEnglish (US)
Pages (from-to)236-242
Number of pages7
JournalCancer Journal
Volume15
Issue number3
DOIs
StatePublished - May 2009

Fingerprint

Patient Selection
Carcinoma
Tumor Burden
Drug Therapy
Histology
Appendiceal Neoplasms
Learning Curve
Standard of Care
Colonic Neoplasms
Multivariate Analysis
Neoplasm Metastasis
Survival
Liver
Neoplasms
Therapeutics

Keywords

  • Cytoreductive surgery
  • Hyperthermic intraperitoneal chemotherapy
  • Patient selection
  • Peritoneal carcinomatosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Piso, P., Glockzin, G., Von Breitenbuch, P., Sulaiman, T., Popp, F., Dahlke, M., ... Schlitt, H. J. (2009). Patient selection for a curative approach to carcinomatosis. Cancer Journal, 15(3), 236-242. https://doi.org/10.1097/PPO.0b013e3181a58f30

Patient selection for a curative approach to carcinomatosis. / Piso, Pompiliu; Glockzin, Gabriel; Von Breitenbuch, Phillip; Sulaiman, Talal; Popp, Felix; Dahlke, Marc; Esquivel, Jesus; Schlitt, Hans Juergen.

In: Cancer Journal, Vol. 15, No. 3, 05.2009, p. 236-242.

Research output: Contribution to journalArticle

Piso, P, Glockzin, G, Von Breitenbuch, P, Sulaiman, T, Popp, F, Dahlke, M, Esquivel, J & Schlitt, HJ 2009, 'Patient selection for a curative approach to carcinomatosis', Cancer Journal, vol. 15, no. 3, pp. 236-242. https://doi.org/10.1097/PPO.0b013e3181a58f30
Piso P, Glockzin G, Von Breitenbuch P, Sulaiman T, Popp F, Dahlke M et al. Patient selection for a curative approach to carcinomatosis. Cancer Journal. 2009 May;15(3):236-242. https://doi.org/10.1097/PPO.0b013e3181a58f30
Piso, Pompiliu ; Glockzin, Gabriel ; Von Breitenbuch, Phillip ; Sulaiman, Talal ; Popp, Felix ; Dahlke, Marc ; Esquivel, Jesus ; Schlitt, Hans Juergen. / Patient selection for a curative approach to carcinomatosis. In: Cancer Journal. 2009 ; Vol. 15, No. 3. pp. 236-242.
@article{162ec11038f74605a134c43a45d126e0,
title = "Patient selection for a curative approach to carcinomatosis",
abstract = "There is an increasing evidence showing that in selected patients with peritoneal carcinomatosis cytoreductive surgery and hyperthermic intraperitoneal chemotherapy may improve survival. Adequate patient selection is crucial to obtain a complete macroscopic cytoreduction, a leading predictor of patient outcome. However, selection is a very difficult process and is associated with a significant learning curve. Many selection criteria have to be assessed in each patient: performance status, comorbiditites, response to previous chemotherapies, histology grading, and presence of extra-abdominal or liver metastases, small bowel involvement, and tumor volume assessed by the peritoneal cancer index. All these factors have to be discussed interdisciplinary and with the patient to create an individualized treatment strategy. It is difficult to decide the relative importance of each selection criteria. However, completeness of cytoreduction, tumor volume, and histology grading are most important in many multivariate analysis independent prognostic factors. For appropriate selected patients with peritoneal carcinomatosis arising from appendiceal and colon cancer, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy should be considered standard of care.",
keywords = "Cytoreductive surgery, Hyperthermic intraperitoneal chemotherapy, Patient selection, Peritoneal carcinomatosis",
author = "Pompiliu Piso and Gabriel Glockzin and {Von Breitenbuch}, Phillip and Talal Sulaiman and Felix Popp and Marc Dahlke and Jesus Esquivel and Schlitt, {Hans Juergen}",
year = "2009",
month = "5",
doi = "10.1097/PPO.0b013e3181a58f30",
language = "English (US)",
volume = "15",
pages = "236--242",
journal = "Cancer journal (Sudbury, Mass.)",
issn = "0765-7846",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "3",

}

TY - JOUR

T1 - Patient selection for a curative approach to carcinomatosis

AU - Piso, Pompiliu

AU - Glockzin, Gabriel

AU - Von Breitenbuch, Phillip

AU - Sulaiman, Talal

AU - Popp, Felix

AU - Dahlke, Marc

AU - Esquivel, Jesus

AU - Schlitt, Hans Juergen

PY - 2009/5

Y1 - 2009/5

N2 - There is an increasing evidence showing that in selected patients with peritoneal carcinomatosis cytoreductive surgery and hyperthermic intraperitoneal chemotherapy may improve survival. Adequate patient selection is crucial to obtain a complete macroscopic cytoreduction, a leading predictor of patient outcome. However, selection is a very difficult process and is associated with a significant learning curve. Many selection criteria have to be assessed in each patient: performance status, comorbiditites, response to previous chemotherapies, histology grading, and presence of extra-abdominal or liver metastases, small bowel involvement, and tumor volume assessed by the peritoneal cancer index. All these factors have to be discussed interdisciplinary and with the patient to create an individualized treatment strategy. It is difficult to decide the relative importance of each selection criteria. However, completeness of cytoreduction, tumor volume, and histology grading are most important in many multivariate analysis independent prognostic factors. For appropriate selected patients with peritoneal carcinomatosis arising from appendiceal and colon cancer, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy should be considered standard of care.

AB - There is an increasing evidence showing that in selected patients with peritoneal carcinomatosis cytoreductive surgery and hyperthermic intraperitoneal chemotherapy may improve survival. Adequate patient selection is crucial to obtain a complete macroscopic cytoreduction, a leading predictor of patient outcome. However, selection is a very difficult process and is associated with a significant learning curve. Many selection criteria have to be assessed in each patient: performance status, comorbiditites, response to previous chemotherapies, histology grading, and presence of extra-abdominal or liver metastases, small bowel involvement, and tumor volume assessed by the peritoneal cancer index. All these factors have to be discussed interdisciplinary and with the patient to create an individualized treatment strategy. It is difficult to decide the relative importance of each selection criteria. However, completeness of cytoreduction, tumor volume, and histology grading are most important in many multivariate analysis independent prognostic factors. For appropriate selected patients with peritoneal carcinomatosis arising from appendiceal and colon cancer, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy should be considered standard of care.

KW - Cytoreductive surgery

KW - Hyperthermic intraperitoneal chemotherapy

KW - Patient selection

KW - Peritoneal carcinomatosis

UR - http://www.scopus.com/inward/record.url?scp=67651171311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651171311&partnerID=8YFLogxK

U2 - 10.1097/PPO.0b013e3181a58f30

DO - 10.1097/PPO.0b013e3181a58f30

M3 - Article

VL - 15

SP - 236

EP - 242

JO - Cancer journal (Sudbury, Mass.)

JF - Cancer journal (Sudbury, Mass.)

SN - 0765-7846

IS - 3

ER -